Guardant Health valuation

GH · NASDAQ · USD

Compare Guardant Health
$143.28Change from previous close: −0.52%Absolute change: −$0.75

Close · November 17, 2026

Valuation

The average price target of 25 analysts is $200.76.

Data as of November 15, 2026

Guardant Health compared with similar companies

Guardant Health's metrics compared with similar companies
MetricGuardant HealthMedian25th–75th percentileBand
Price/sales16.06.202.45 – 7.36High
Gross margin65.2%55.9%33.1% – 65.2%High
Operating margin-39.4%14.3%6.9% – 17.7%Low
Net margin-37.9%8.1%3.1% – 13.9%Low
ROE171.6%13.4%3.8% – 29.6%High
Debt/equity-7.610.740.34 – 0.83Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$20.52B
Enterprise value
$21.19B
P/E (trailing 12 months)
-52.5
Forward P/E
-547.2
Price/book
-107.5
EV/EBITDA
-45.6
EV/revenue
16.6

Profitability and growth

ROA
-19.9%
ROIC
-23.4%
Revenue growth (year over year)
36.1%
Earnings growth (year over year)
12.3%

Financial health

Total cash
$1.03B
Total debt
$1.69B
Current ratio
3.60
Quick ratio
3.25
Altman Z-Score
2.15
Piotroski F-Score
4.00

Dividends

Dividend yield
0.0%

Analysts and estimates

Average price target
$200.76
Median price target
$200.00
High price target
$240.00
Low price target
$105.00
Analysts with a price target
25
Consensus
Strong buy
Forward EPS
-$0.28
EPS estimate, current year
-$1.46

Shares and trading

Beta
1.66
Average volume
2.02M
Shares outstanding
135.29M
Float
130.57M
Institutional ownership
98.7%
Insider ownership
4.6%
Short interest (% of float)
7.3%
Short ratio (days)
5.32